Whether mds to AML can be survived in the long term is related to the severity of the disease. If the disease is not particularly severe, then the progression of the disease can be controlled by a combination of chemotherapy or bone marrow transplantation to achieve long-term survival. However, if the disease is severe, long-term survival is less likely.
The term mds refers to myelodysplastic syndromes, which are diseases of bone marrow proliferation that can be linked to genetics, infections, and long-term exposure to chemicals. For most patients, if mds turns into acute myeloid leukemia, it means that the condition has deteriorated and is prone to life-threatening bleeding, infection, and anemia in a short period of time.
The prognosis is not very good as most patients will have some drug resistance. However, this does not mean that the disease is completely incurable. If the patient’s condition is not particularly serious and he or she goes to the hospital in time for combination chemotherapy or a bone marrow transplant, then there is a chance of long-term survival. However, if the disease is severe, then it is basically difficult to survive for a long time.
The treatment drugs include cytarabine, Zorubicin, decitabine and so on.
In the course of treatment, patients should strictly follow the doctor’s arrangement, comply with the doctor’s instructions, pay attention to personal hygiene, eat more fresh vegetables and fruits, and go to the hospital for regular checkups, so as to effectively prolong the survival time.